EP1215135A1 - Bottle for photosensitive dyes - Google Patents

Bottle for photosensitive dyes Download PDF

Info

Publication number
EP1215135A1
EP1215135A1 EP01430036A EP01430036A EP1215135A1 EP 1215135 A1 EP1215135 A1 EP 1215135A1 EP 01430036 A EP01430036 A EP 01430036A EP 01430036 A EP01430036 A EP 01430036A EP 1215135 A1 EP1215135 A1 EP 1215135A1
Authority
EP
European Patent Office
Prior art keywords
bottle
phycoerythrin
radiation
visible
fluorochromes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP01430036A
Other languages
German (de)
French (fr)
Other versions
EP1215135A8 (en
EP1215135B1 (en
Inventor
désignation de l'inventeur n'a pas encore été déposée La
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunotech SAS
Original Assignee
Immunotech SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunotech SAS filed Critical Immunotech SAS
Publication of EP1215135A1 publication Critical patent/EP1215135A1/en
Publication of EP1215135A8 publication Critical patent/EP1215135A8/en
Application granted granted Critical
Publication of EP1215135B1 publication Critical patent/EP1215135B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/24Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants
    • B65D81/30Adaptations for preventing deterioration or decay of contents; Applications to the container or packaging material of food preservatives, fungicides, pesticides or animal repellants by excluding light or other outside radiation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/13Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/131Glass, ceramic, or sintered, fused, fired, or calcined metal oxide or metal carbide containing [e.g., porcelain, brick, cement, etc.]
    • Y10T428/1317Multilayer [continuous layer]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/13Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/131Glass, ceramic, or sintered, fused, fired, or calcined metal oxide or metal carbide containing [e.g., porcelain, brick, cement, etc.]
    • Y10T428/1317Multilayer [continuous layer]
    • Y10T428/1321Polymer or resin containing [i.e., natural or synthetic]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/13Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/1352Polymer or resin containing [i.e., natural or synthetic]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/13Hollow or container type article [e.g., tube, vase, etc.]
    • Y10T428/1352Polymer or resin containing [i.e., natural or synthetic]
    • Y10T428/139Open-ended, self-supporting conduit, cylinder, or tube-type article
    • Y10T428/1393Multilayer [continuous layer]

Definitions

  • the present invention relates to new packaging for photosensitive dyes and a new method of packaging fluorochromatic reagents for cytometry.
  • Flow cytometry is a very specific cell analysis technique used for decades. This technique involves at least one fluorochrome.
  • the main fluorochromes used in cytometry are fluorescein isothiocyanate (FITC), phycoerythrin (PE), allophycocyanin (APC), PercP, tandems phycoerythrin-cyanine 5 (PC5), phycoerythrin-cyanine 7 (PC7) and phycoerythrin-texas red (ECD or PETR).
  • FITC fluorescein isothiocyanate
  • PE phycoerythrin
  • APC allophycocyanin
  • PercP PercP
  • PC5 phycoerythrin-cyanine 5
  • PC7 phycoerythrin-cyanine 7
  • ECD or PETR phycoerythrin-texas red
  • the tandems PC5, PC7, ECD use the principle of transfer of energy, i.e. the laser of the cytometer excites the molecule in the area spectral of phycoerythrin which restores the energy absorbed to the molecule acceptor (cyanine 5, cyanine 7 or Texas red) which will return it itself in radiative form at its emission wavelength.
  • the laser of the cytometer excites the molecule in the area spectral of phycoerythrin which restores the energy absorbed to the molecule acceptor (cyanine 5, cyanine 7 or Texas red) which will return it itself in radiative form at its emission wavelength.
  • Tandem dyes nevertheless absorb light throughout spectral zone and particularly in the visible zone (400-800 nm) and the Applicant has realized that these fluorochromes, alone or in tandem, were subject to significant degradation during their conservation.
  • tandem phycoerythrin-allophycocyanin has been described for some time 20 years (Glazer et al. Biophys. J. (1983) 83, 383-386 and the tandems phycoerythrin-cyanine 5 for almost 10 years Lanier et al. Methods (1991) Vol 2 N ° 3 192-199. Since then, this kind of product has been marketed in bottles of brown or amber glass by BECTON DICKINSON Companies, PHARMINGEN, DAKO, IQP, or CALTAG.
  • the invention is based on the use of bottles opaque to radiation bright tandem exciters, i.e. between 200 and 900 nm and more particularly between 400 and 800 nm.
  • the present request relates to packaging.
  • Fluorochrome sensitive to visible light means a fluorochrome whose structure is degraded by emission at the indicated wavelengths, by example fluorescein isothiocyanate (FITC), phycoerythrin (PE), allophycocyanin (APC), PercP, phycoerythrin-cyanine tandems 7 (PC7), phycoerythrin-cyanine 5 (PC5) and phycoerythrin-texas red (ECD or PETR), preferably the latter two.
  • FITC fluorescein isothiocyanate
  • PE phycoerythrin
  • APC allophycocyanin
  • PercP phycoerythrin-cyanine tandems 7
  • PC5 phycoerythrin-cyanine 5
  • ECD or PETR phycoerythrin-texas red
  • the terms “form an effective screen radiation” means that at least 95%, preferably at least 98%, particularly at least 99% and especially 100% of radiation from visible are stopped by the side walls of the bottle due to their structure (nature, treatment or sheathing in particular).
  • the term “bottle” refers to preferably a small bottle preferably with a screw, fitted with a cap with or without septum.
  • the bottle can be made of polyethylene, polypropylene, polycarbonate, but preferably glass. Its capacity can preferably range from 50 ⁇ l to 50 ml, especially from 100 ⁇ l to 20 ml, especially from 500 ⁇ l to 10 ml and all especially from 1 ml to 10 ml. For example, a 5 ml bottle can be filled per 1 to 2 ml of solution.
  • glass vials of about 5 ml.
  • the bottom of the bottle also forms an effective radiation shield visible.
  • Sheathing techniques are already known in perfumery or coating of vials forming an effective shield against spectrum radiation visible, used for aesthetic purposes.
  • Examples include powder coating electrostatic which consists in surrounding the bottles with a septum which is pierced by an electrode which is installed in the bottle to be covered.
  • the vials are placed in an enclosure containing a powder sprayed, charged with a sign opposite to that of the bottle.
  • the powder is deposited then on the bottle on which it is fixed for example by cooking in an oven at around 180 ° C.
  • a epoxy resin powder preferably absorbing in the wavelengths above indicated, particularly 600 to 800 nanometers, black or blue in particular.
  • the packaging object of the present invention have very interesting properties.
  • the use of covered or treated bottles as described above eliminates the photoinduced oxidation phenomenon and provides excellent stability to fluorochromes-antibody conjugates or Tandem-antibodies.
  • the present invention also applies to other conjugates antibody-tandems than those mentioned above, as well as all fluorochromes used in flow cytometry.
  • the present application also relates to a method for protecting fluorochromes sensitive to visible light and particularly to lengths wave ranging from 400 to 600 nanometers during their conservation, in which installs said fluorochromes in a bottle with at least the side walls have a structure that forms an effective screen for radiation from the light spectrum between 200 and 800 nm, particularly at wavelengths ranging from 400 to 800 nanometers, more particularly from 400 to 700 nanometers and particularly between 400 and 600 nm.
  • Example 1 Coating of a glass bottle with epoxy resin
  • Example 3 Manufacture of a glass vial covered with epoxy resin filled with a solution of anti-CD3-Phycoerythrin-cyanine antibody conjugates in PBS, BSA 2 mg / ml, sodium azide 0.1%.
  • Vials made according to Example 1 were filled with each 2 ml solution of anti-CD3-Phycoerythrin-cyanine antibody conjugates 5 in phosphate buffer / bovine serum albumin (2 mg / ml) / azide 0.1% sodium.
  • flasks commercial and modified products containing anti-CD3 antibodies conjugated to PC5 and ECD fluorochromes underwent a forced degradation test according to the method described in good manufacturing practices (Good Manufacturing Practice (GMP)) of the US Food and Drug Administration.
  • GMP Good Manufacturing Practice
  • Figure 1 shows the excellent protection of the contents of the vials in implementing the invention.
  • the tandems introduced in the bottle BeckmanCoulter Immunotech from the IOTEST range covered with a layer of epoxy varnish according to the electrostatic powdering process have a autofluorescence in FL2 identical to that of the non-irradiated control.
  • all the other types of bottles show a light permeability which is translated by a "leak" in FL2, ie an increase in autofluorescence with the appearance of false positive cells.

Landscapes

  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Mechanical Engineering (AREA)
  • Packages (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

Package that comprises a light-sensitive fluorochrome (I) is a bottle, at least the sides of which form a screen against light of wavelength 200-900 nm.

Description

La présente invention concerne de nouveaux conditionnements pour colorants photosensibles et une nouvelle méthode de conditionnement de réactifs à base de fluorochromes pour la cytométrie.The present invention relates to new packaging for photosensitive dyes and a new method of packaging fluorochromatic reagents for cytometry.

La cytométrie de flux est une technique d'analyse de cellules très utilisée depuis des décennies. Cette technique met en jeu au moins un fluorochrome.Flow cytometry is a very specific cell analysis technique used for decades. This technique involves at least one fluorochrome.

C'est un outil puissant pour l'analyse antigénique cellulaire. Cette technique permet d'analyser plusieurs cibles antigéniques en même temps grâce à des combinaisons d'anticorps conjugués à des fluorochromes. Les principaux fluorochromes utilisés en cytométrie sont la fluorescéine isothiocyanate (FITC), la phycoérythrine (PE), l'allophycocyanine (APC), le PercP, les tandems phycoérythrine-cyanine 5 (PC5), phycoérythrine-cyanine 7 (PC7) et phycoérythrine-texas red (ECD ou PETR). Ces fluorochromes absorbent les radiations lumineuses particulièrement à 488 nm et 633 nm qui sont les principales longueurs d'ondes d'émission des lasers utilisés sur les cytomètres. Les tandems PC5, PC7, ECD utilisent le principe du transfert d'énergie, c'est à dire que le laser du cytomètre excite la molécule dans la zone spectrale de la phycoérythrine qui restitue l'énergie absorbée à la molécule accepteuse (cyanine 5, cyanine 7 ou Texas red) qui va elle même la restituer sous forme radiative à sa longueur d'onde d'émission.It is a powerful tool for cellular antigen analysis. This technique allows to analyze several antigenic targets at the same time thanks to combinations of antibodies conjugated to fluorochromes. The main fluorochromes used in cytometry are fluorescein isothiocyanate (FITC), phycoerythrin (PE), allophycocyanin (APC), PercP, tandems phycoerythrin-cyanine 5 (PC5), phycoerythrin-cyanine 7 (PC7) and phycoerythrin-texas red (ECD or PETR). These fluorochromes absorb light radiation particularly at 488 nm and 633 nm which are the main emission wavelengths of the lasers used on the cytometers. The tandems PC5, PC7, ECD use the principle of transfer of energy, i.e. the laser of the cytometer excites the molecule in the area spectral of phycoerythrin which restores the energy absorbed to the molecule acceptor (cyanine 5, cyanine 7 or Texas red) which will return it itself in radiative form at its emission wavelength.

Les colorants tandems absorbent néanmoins la lumière dans toute la zone spectrale et particulièrement dans la zone du visible (400-800 nm) et la demanderesse s'est rendue compte que ces fluorochromes, seuls ou en tandem, faisaient l'objet de dégradations sensibles pendant leur conservation.Tandem dyes nevertheless absorb light throughout spectral zone and particularly in the visible zone (400-800 nm) and the Applicant has realized that these fluorochromes, alone or in tandem, were subject to significant degradation during their conservation.

Ces dégradations induisent une détérioration de l'efficacité du transfert énergétique qui conduit à une augmentation de l'intensité de fluorescence de la phycoérythrine à 580 nm. Ce phénomène se traduit en cytométrie par une augmentation de fluorescence (appelée fuite) dans le canal de la phycoérythrine (FL2) pouvant conduire à différents problèmes :

  • Apparition de cellules faussement positives
  • Nécessité d'augmenter les compensations afin de retrouver les valeurs d'intensité de fluorescence initiales.
These degradations induce a deterioration in the efficiency of the energy transfer which leads to an increase in the fluorescence intensity of phycoerythrin at 580 nm. This phenomenon is expressed in cytometry by an increase in fluorescence (called leakage) in the phycoerythrin channel (FL2) which can lead to various problems:
  • Appearance of false positive cells
  • Need to increase the compensations in order to find the initial fluorescence intensity values.

Le dernier point est particulièrement crucial dans le cas des systèmes informatiques de compensation automatique.The last point is particularly crucial in the case of automatic compensation computer systems.

Le tandem phycoérythrine-allophycocyanine a été décrit depuis près de 20 ans (Glazer et al. Biophys. J. (1983) 83, 383-386 et les tandems phycoérythrine-cyanine 5 depuis près de 10 ans Lanier et al. Methods (1991) Vol 2 N°3 192-199. Depuis, ce genre de produits est commercialisé dans des flacons de verre brun ou ambré par les Sociétés BECTON DICKINSON, PHARMINGEN, DAKO, IQP, ou CALTAG.The tandem phycoerythrin-allophycocyanin has been described for some time 20 years (Glazer et al. Biophys. J. (1983) 83, 383-386 and the tandems phycoerythrin-cyanine 5 for almost 10 years Lanier et al. Methods (1991) Vol 2 N ° 3 192-199. Since then, this kind of product has been marketed in bottles of brown or amber glass by BECTON DICKINSON Companies, PHARMINGEN, DAKO, IQP, or CALTAG.

Il serait donc souhaitable de disposer d'un conditionnement de fluorochromes assurant la conservation desdits fluorochromes pendant une durée prolongée.It would therefore be desirable to have a packaging of fluorochromes ensuring the conservation of said fluorochromes during a extended duration.

Après un certain nombre de tests, la demanderesse a émis l'hypothèse que ces fluorochromes pourraient être sensibles à la lumière visible. Elle a alors recouvert les parois latérales des flacons de fluorochromes d'une gaine thermorétractable absorbant la lumière visible. Une amélioration très sensible a alors été observée, ne donnant toutefois pas encore totale satisfaction. Elle a alors procédé à d'autres essais qui n'apportaient pas de progrès supplémentaire.After a number of tests, the applicant hypothesized that these fluorochromes could be sensitive to visible light. She then covered the side walls of the fluorochromes bottles with a sheath heat shrinkable absorbing visible light. A very noticeable improvement has then observed, however not yet giving complete satisfaction. She has then carried out other tests which did not bring any further progress.

En poursuivant encore ses recherches, la demanderesse a découvert avec étonnement que le fait que le fond des flacons gainés ne soit pas protégés suffisait à dégrader les fluorochromes, lorsque les flacons étaient manipulés ou renversés à plat sur leur côté au lieu d'être posés sur leur fond. Elle a alors compris que ces fluorochromes étaient très sensibles aux longueurs d'onde allant de 200 à 900 nanomètres, notamment à la lumière visible, particulièrement aux longueurs d'onde allant de 400 à 700 nanomètres et singulièrement aux longueurs d'onde allant de 400 à 600 nanomètres.While continuing her research, the plaintiff discovered with astonishment that the fact that the bottom of the sheathed bottles is not protected sufficient to degrade fluorochromes, when the bottles were handled or overturned flat on their side instead of being placed on their bottom. She then understood that these fluorochromes were very sensitive to wavelengths ranging from 200 to 900 nanometers, especially in visible light, particularly at wavelengths ranging from 400 to 700 nanometers and particularly at wavelengths ranging from 400 to 600 nanometers.

Selon la demanderesse, la dégradation des tandems aurait pour origine un phénomène d'oxydation photo induit dans lequel les molécules jouent le rôle de photo sensibilisateur, c'est à dire qu'elles sont capables d'activer l'oxygène :

  • par transfert de l'énergie lumineuse absorbée avec génération d'oxygène singulet (mécanisme dit de type II),
  • par transfert d'électron à l'état excité avec génération de radicaux oxygénés (mécanisme dit de type I).
According to the applicant, the degradation of the tandems originates from a photo-induced oxidation phenomenon in which the molecules play the role of photo-sensitizer, that is to say that they are capable of activating oxygen:
  • by transfer of the absorbed light energy with generation of singlet oxygen (so-called type II mechanism),
  • by electron transfer in the excited state with generation of oxygen radicals (so-called type I mechanism).

L'invention repose sur l'utilisation de flacons opaques aux radiations lumineuses excitatrices des tandems, c'est à dire entre 200 et 900 nm et plus particulièrement entre 400 et 800 nm.The invention is based on the use of bottles opaque to radiation bright tandem exciters, i.e. between 200 and 900 nm and more particularly between 400 and 800 nm.

C'est pourquoi la présente demande a pour objet un conditionnement comprenant un fluorochrome sensible aux longueurs d'onde allant de 200 à 900 nanomètres et singulièrement aux longueurs d'onde allant de 400 à 600 nanomètres placé dans un flacon dont au moins les parois latérales forment un écran efficace aux radiations du spectre lumineux entre 200 et 900 nm, particulièrement aux longueurs d'onde allant de 400 à 800 nanomètres, plus particulièrement de 400 à 700 nanomètres et singulièrement entre 400 et 600 nm.This is why the present request relates to packaging. comprising a fluorochrome sensitive to wavelengths ranging from 200 to 900 nanometers and particularly at wavelengths ranging from 400 to 600 nanometers placed in a bottle of which at least the side walls form a screen effective at radiations of the light spectrum between 200 and 900 nm, particularly at wavelengths from 400 to 800 nanometers, more particularly from 400 to 700 nanometers and particularly between 400 and 600 nm.

Dans la présente demande et dans ce qui suit, les termes «fluorochrome sensible à la lumière visible» désignent un fluorochrome dont la structure est dégradée par une émission aux longueurs d'onde indiquée , par exemple la fluorescéine isothiocyanate (FITC), la phycoérythrine (PE), l'allophycocyanine (APC), le PercP, les tandems phycoérythrine-cyanine 7 (PC7), phycoérythrine-cyanine 5 (PC5) et phycoérythrine-texas red (ECD ou PETR), de préférence ces deux derniers. Les termes «forment un écran efficace aux radiations» signifient que au moins 95 %, de préférence au moins 98 %, particulièrement au moins 99 % et tout particulièrement 100% des radiations du visible sont stoppées par les parois latérales du flacon en raison de leur structure (nature, traitement ou gainage notamment). Le terme « flacon» désigne de préférence une petite bouteille de préférence à vis, équipée d'un bouchon avec ou sans septum. Le flacon peut être en polyéthylène, polypropylène, polycarbonate, mais de préférence en verre. Sa capacité peut aller de préférence de 50 µl à 50 ml, notamment de 100 µl à 20 ml, particulièrement de 500 µl à 10 ml et tout particulièrement de 1 ml à 10 ml. Un flacon de 5 ml peut par exemple être rempli par 1 à 2 ml de solution.In the present application and in the following, the terms "Fluorochrome sensitive to visible light" means a fluorochrome whose structure is degraded by emission at the indicated wavelengths, by example fluorescein isothiocyanate (FITC), phycoerythrin (PE), allophycocyanin (APC), PercP, phycoerythrin-cyanine tandems 7 (PC7), phycoerythrin-cyanine 5 (PC5) and phycoerythrin-texas red (ECD or PETR), preferably the latter two. The terms "form an effective screen radiation "means that at least 95%, preferably at least 98%, particularly at least 99% and especially 100% of radiation from visible are stopped by the side walls of the bottle due to their structure (nature, treatment or sheathing in particular). The term "bottle" refers to preferably a small bottle preferably with a screw, fitted with a cap with or without septum. The bottle can be made of polyethylene, polypropylene, polycarbonate, but preferably glass. Its capacity can preferably range from 50 µl to 50 ml, especially from 100 µl to 20 ml, especially from 500 µl to 10 ml and all especially from 1 ml to 10 ml. For example, a 5 ml bottle can be filled per 1 to 2 ml of solution.

On préfère tout particulièrement des flacons de verre de 5 ml environ.Particularly preferred are glass vials of about 5 ml.

Dans des conditions préférentielles de mise en oeuvre de l'invention, le fond du flacon forme également un écran efficace aux radiations du spectre visible. Under preferential conditions for implementing the invention, the bottom of the bottle also forms an effective radiation shield visible.

Il est déjà connu en parfumerie des techniques de gainage ou revêtement de flacons formant un écran efficace aux radiations du spectre visible, utilisées à des fins esthétiques.Sheathing techniques are already known in perfumery or coating of vials forming an effective shield against spectrum radiation visible, used for aesthetic purposes.

On peut citer par exemple le revêtement par poudrage électrostatique qui consiste à entourer les flacons d'un septum qui est transpercé par une électrode qui est installée dans le flacon à recouvrir. Les flacons sont placés dans une enceinte dans laquelle se trouve une poudre pulvérisée, chargée d'un signe opposé à celui du flacon. La poudre se dépose alors sur le flacon sur lequel elle est fixée par exemple par cuisson dans un four à environ 180°C. Dans le cadre de l'invention, on peut utiliser par exemple une poudre de résine époxy absorbant de préférence dans les longueurs d'ondes ci-dessus indiquées, particulièrement 600 à 800 nanomètres, de couleur noire ou bleue notamment.Examples include powder coating electrostatic which consists in surrounding the bottles with a septum which is pierced by an electrode which is installed in the bottle to be covered. The vials are placed in an enclosure containing a powder sprayed, charged with a sign opposite to that of the bottle. The powder is deposited then on the bottle on which it is fixed for example by cooking in an oven at around 180 ° C. In the context of the invention, it is possible, for example, to use a epoxy resin powder preferably absorbing in the wavelengths above indicated, particularly 600 to 800 nanometers, black or blue in particular.

On peut aussi gainer le flacon d'une gaine avantageusement thermorétractable recouvrant de préférence également le fond du flacon.You can also sheath the bottle with a sheath advantageously heat shrink preferably also covering the bottom of the bottle.

On peut encore irradier certains types de verres par rayonnement gamma.We can still irradiate certain types of glasses by radiation gamma.

On peut tout autant effectuer un surmoulage à l'aide d'un film plastique, ce qui offre l'avantage de pouvoir recouvrir le fond des flacons.It is just as possible to make a molding using a film plastic, which has the advantage of being able to cover the bottom of the bottles.

Les conditionnements objet de la présente invention possèdent de très intéressantes propriétés. L'utilisation de flaconnages recouverts ou traités comme décrit ci-dessus supprime le phénomène d'oxydation photoinduit et confère une excellente stabilité aux conjugués fluorochromes-anticorps ou tandems-anticorps.The packaging object of the present invention have very interesting properties. The use of covered or treated bottles as described above eliminates the photoinduced oxidation phenomenon and provides excellent stability to fluorochromes-antibody conjugates or Tandem-antibodies.

Ces propriétés sont illustrées ci-après dans la partie expérimentale.These properties are illustrated below in the experimental part.

La présente invention s'applique également aux autres conjugués anticorps-tandems que ceux cités ci-dessus, ainsi qu'à tous les fluorochromes utilisés en cytométrie en flux.The present invention also applies to other conjugates antibody-tandems than those mentioned above, as well as all fluorochromes used in flow cytometry.

La présente demande a aussi pour objet un procédé de protection de fluorochromes sensibles à la lumière visible et singulièrement aux longueurs d'onde allant de 400 à 600 nanomètres lors de leur conservation, dans lequel on installe lesdits fluorochromes dans un flacon dont au moins les parois latérales ont une structure qui forme un écran efficace aux radiations du spectre lumineux entre 200 et 800 nm, particulièrement aux longueurs d'onde allant de 400 à 800 nanomètres, plus particulièrement de 400 à 700 nanomètres et singulièrement entre 400 et 600 nm.The present application also relates to a method for protecting fluorochromes sensitive to visible light and particularly to lengths wave ranging from 400 to 600 nanometers during their conservation, in which installs said fluorochromes in a bottle with at least the side walls have a structure that forms an effective screen for radiation from the light spectrum between 200 and 800 nm, particularly at wavelengths ranging from 400 to 800 nanometers, more particularly from 400 to 700 nanometers and particularly between 400 and 600 nm.

Les conditions préférentielles de mise en oeuvre des conditionnements ci-dessus décrites s'appliquent également aux autres objets de l'invention visés ci-dessus, notamment au procédé de protection de fluorochromes.Preferential conditions for the implementation of packaging described above also apply to the other objects of the invention referred to above, in particular to the process for protecting fluorochromes.

Les exemples qui suivent illustrent la présente demande.

  • les figures 1A, B, C, D et E représentent les résultats de fluorescence obtenus avec des échantillons de conjugués Anticorps anti-CD3-Phycoérythrine-cyanine 5 contenus dans leur flacon d'origine ou d'un flacon selon l'invention, et soumis à l'action de la lumière, et
  • les figures 2A, B, C et D représentent les résultats de fluorescence obtenus avec des échantillons de conjugués Anticorps anti-CD19-Phycoérythrine-texas red contenus dans leur flacon d'origine ou d'un flacon selon l'invention, et soumis à l'action de la lumière.
The following examples illustrate the present application.
  • FIGS. 1A, B, C, D and E represent the fluorescence results obtained with samples of anti-CD3-Phycoerythrin-cyanine antibody conjugates contained in their original bottle or in a bottle according to the invention, and subjected to the action of light, and
  • FIGS. 2A, B, C and D represent the fluorescence results obtained with samples of anti-CD19-Phycoerythrin-texas red antibody conjugates contained in their original bottle or in a bottle according to the invention, and subjected to l action of light.

Plus précisément,

  • les figures 1A et 2A concernent un conjugué protégé de la lumière, servant de témoin,
  • les figures 1B et 2B concernent un conjugué conditionné dans un flacon de verre commercial BeckmanCoulter Immunotech de la gamme IOTEST,
  • les figures 1C et 2C concernent un conjugué conditionné dans un flacon de verre commercial BeckmanCoulter Immunotech de la gamme Cytostat,
  • la figure 1D concerne un conjugué conditionné dans un flacon de verre commercial BECTON DICKINSON Pharmingen, et
  • les figures 1E et 2D concernent un conjugué conditionné dans un flacon de verre commercial BeckmanCoulter Immunotech de la gamme IOTEST recouvert d'une couche de vernis époxy selon le procédé de poudrage électrostatique de l'exemple 1.
More precisely,
  • FIGS. 1A and 2A relate to a conjugate protected from light, serving as a control,
  • FIGS. 1B and 2B relate to a conjugate packaged in a BeckmanCoulter Immunotech commercial glass bottle from the IOTEST range,
  • FIGS. 1C and 2C relate to a conjugate packaged in a BeckmanCoulter Immunotech commercial glass bottle from the Cytostat range,
  • FIG. 1D relates to a conjugate packaged in a BECTON DICKINSON Pharmingen commercial glass bottle, and
  • FIGS. 1E and 2D relate to a conjugate packaged in a BeckmanCoulter Immunotech commercial glass bottle from the IOTEST range covered with a layer of epoxy varnish according to the electrostatic powdering process of Example 1.

Exemple 1 : Revêtement d'un flacon de verre à l'aide de résine époxy Example 1 : Coating of a glass bottle with epoxy resin

On place des flacons commerciaux en verre destinés à recevoir des conjugués Anticorps anti-CD3-Phycoérythrine-cyanine 5 de BeckmanCoulter Immunotech de la gamme IOTEST dans une chaíne mettant en oeuvre les étapes suivantes :

  • On lave les flacons.
  • On les passe dans un four de séchage.
  • On les passe ensuite dans une cabine dans laquelle les flacons sont recouverts d'un septum transpercé par une électrode.
  • La poudre de résine époxy Noir mat AKZO référence NOIR MAT 1P200 8391 (nouvelle référence AN052F) de charge opposée à celle de l'électrode pulvérisée dans la cabine s'applique par phénomène électrostatique sur la surface des flacons que l'on fait alors passer dans un four de cuisson à 180°C.
  • Commercial glass bottles are placed intended to receive anti-CD3-Phycoerythrin-cyanine 5 antibody conjugates from BeckmanCoulter Immunotech of the IOTEST range in a chain implementing the following steps:
  • We wash the bottles.
  • They are passed through a drying oven.
  • They are then passed through a cabin in which the bottles are covered with a septum pierced by an electrode.
  • AKZO matt black epoxy resin powder reference BLACK MAT 1P200 8391 (new reference AN052F) with a charge opposite to that of the electrode sprayed in the booth is applied by electrostatic phenomenon to the surface of the bottles which are then passed through a baking oven at 180 ° C.
  • Exemple 2 : Revêtement d'un flacon de verre à l'aide de gaine thermo-rétractable de polyéthylène EXAMPLE 2 Coating of a Glass Vial Using Polyethylene Heat Shrink Tubing

    On a recouvert les côtés et le col de flacons commerciaux de 6ml en verre destinés à recevoir des conjugués Anticorps anti-CD3-Phycoérythrine-cyanine 5 de Beckman Coulter Immunotech de la gamme IOTEST à l'aide de gaine thermo-rétractable de polyéthylène commercialisée par la société SLEEVER INTERNATIONAL.We covered the sides and the neck with 6ml commercial bottles in glass intended to receive anti-CD3-Phycoerythrin-cyanine antibody conjugates 5 of Beckman Coulter Immunotech from the IOTEST range using polyethylene heat-shrink tubing sold by the company SLEEVER INTERNATIONAL.

    Exemple 3 : Fabrication d'un flacon de verre recouvert de résine époxy rempli d'une solution de conjugués Anticorps anti-CD3-Phycoérythrine-cyanine 5 dans du PBS, de la BSA 2mg/ml, azide de sodium 0,1%. Example 3 : Manufacture of a glass vial covered with epoxy resin filled with a solution of anti-CD3-Phycoerythrin-cyanine antibody conjugates in PBS, BSA 2 mg / ml, sodium azide 0.1%.

    On a rempli des flacons fabriqués selon l'exemple 1 avec chacun 2 ml d'une solution de conjugués Anticorps anti-CD3-Phycoérythrine-cyanine 5 dans du tampon phosphate / sérum albumine bovine (2 mg/ml) / azoture de sodium 0,1%.Vials made according to Example 1 were filled with each 2 ml solution of anti-CD3-Phycoerythrin-cyanine antibody conjugates 5 in phosphate buffer / bovine serum albumin (2 mg / ml) / azide 0.1% sodium.

    Exemple 4 : Essai de conservation de conjugués Anticorps anti-CD3-Phycoérythrine-cyanine 5 Example 4 : Preservation test of anti-CD3-Phycoerythrin-cyanine antibody conjugates 5

    Afin de démontrer l'efficacité du procédé de l'invention, des flacons commerciaux et modifiés contenant des anticorps anti-CD3 conjugués à des fluorochromes PC5 et ECD ont subi un test de dégradation forcé selon la méthode décrite dans les bonnes pratiques de fabrication (Good Manufacturing Practice (GMP)) de la Food and Drug Administration américaine.In order to demonstrate the effectiveness of the process of the invention, flasks commercial and modified products containing anti-CD3 antibodies conjugated to PC5 and ECD fluorochromes underwent a forced degradation test according to the method described in good manufacturing practices (Good Manufacturing Practice (GMP)) of the US Food and Drug Administration.

    Différents conditionnements ont été testés :

    • Flacon commercial BeckmanCoulter Immunotech de la gamme IOTEST
    • Flacon commercial BeckmanCoulter Immunotech de la gamme Cytostat
    • Flacon commercial BeckmanCoulter Immunotech de la gamme IOTEST recouvert d'une couche de vernis époxy selon le procédé de poudrage électrostatique
    • Flacon commercial BECTON DICKINSON Pharmingen.
    Different packaging has been tested:
    • BeckmanCoulter Immunotech commercial bottle from the IOTEST range
    • BeckmanCoulter Immunotech commercial bottle from the Cytostat range
    • BeckmanCoulter Immunotech commercial bottle from the IOTEST range covered with a layer of epoxy varnish using the electrostatic powdering process
    • BECTON DICKINSON Pharmingen commercial bottle.

    Ces flacons contenant les conjugués anticorps-tandems ont été introduits dans une chambre équipée de tubes fluorescents et ont été soumis à une dose lumineuse totale de 1,2.106 lux.h.These bottles containing the antibody-tandem conjugates were introduced into a chamber equipped with fluorescent tubes and were subjected to a total light dose of 1.2 × 10 6 lux.h.

    La figure 1 montre l'excellente protection du contenu des flacons en mettant en oeuvre l'invention. En effet les tandems introduits dans le flacon BeckmanCoulter Immunotech de la gamme IOTEST recouvert d'une couche de vernis époxy selon le procédé de poudrage électrostatique présentent une autofluorescence en FL2 identique à celle du témoin non irradié. En revanche tous les autres types de flaconnage montrent une perméabilité lumineuse qui se traduit par une « fuite » en FL2, c'est à dire une augmentation de l'autofluorescence avec apparition de cellules faussement positives.Figure 1 shows the excellent protection of the contents of the vials in implementing the invention. Indeed the tandems introduced in the bottle BeckmanCoulter Immunotech from the IOTEST range covered with a layer of epoxy varnish according to the electrostatic powdering process have a autofluorescence in FL2 identical to that of the non-irradiated control. On the other hand all the other types of bottles show a light permeability which is translated by a "leak" in FL2, ie an increase in autofluorescence with the appearance of false positive cells.

    Exemple 5 : Essai de conservation de conjugués Anticorps anti-CD19- phycoérythrine-texas red EXAMPLE 5 Preservation Test for Anti-CD19-phycoerythrin-texas Red Antibody Conjugates

    On a opéré comme à l'exemple 4, mais avec des conjugués Anticorps anti-CD19-phycoérythrine-texas red. Les résultats sont donnés à la figure 2.We operated as in Example 4, but with conjugates Anti-CD19-phycoerythrin-texas red antibodies. The results are given to the figure 2.

    L'analyse des résultats conduit aux mêmes conclusions qu'à l'exemple 4.Analysis of the results leads to the same conclusions as Example 4.

    Claims (7)

    Un conditionnement comprenant un ensemble constitué d'un fluorochrome sensible à la lumière visible et d'un flacon dans lequel il est placé, au moins les parois latérales dudit flacon formant un écran efficace aux radiations du spectre lumineux entre 200 et 900 nm.A package comprising a set consisting of a fluorochrome sensitive to visible light and a bottle in which it is placed, at least the side walls of said bottle forming an effective radiation shield of the light spectrum between 200 and 900 nm. Un conditionnement selon la revendication 1, caractérisé en ce que le fond du flacon forme également un écran efficace aux radiations du spectre visible.A package according to claim 1, characterized in that the bottom of the bottle also forms an effective screen for radiation from the visible spectrum. Un conditionnement selon la revendication 1 ou 2, caractérisé en ce que l'effet écran efficace aux radiations est obtenu par revêtement par poudrage électrostatique, par gainage du flacon d'une gaine, par irradiation de certains types de verres par rayonnement gamma, ou par surmoulage.A packaging according to claim 1 or 2, characterized in that the effective radiation shielding effect is obtained by coating by electrostatic powdering, by sheathing the bottle of a sheath, by irradiation of certain types of glasses by gamma radiation, or by overmolding. Un conditionnement selon l'une des revendications 1 à 3, caractérisé en ce que le fluorochrome est choisi parmi la fluorescéine isothiocyanate (FITC), la phycoérythrine (PE), l'allophycocyanine (APC), le PercP, ou fait partie des tandems phycoérythrine-cyanine 7 (PC7), phycoérythrine-cyanine 5 (PC5) et phycoérythrine-texas red (ECD ou PETR).A packaging according to one of claims 1 to 3, characterized in that the fluorochrome is chosen from fluorescein isothiocyanate (FITC), phycoerythrin (PE), allophycocyanin (APC), PercP, or is one of the phycoerythrin tandems -cyanine 7 (PC7), phycoerythrin-cyanine 5 (PC5) and phycoerythrin-texas red (ECD or PETR). Un conditionnement selon l'une des revendications 1 à 4, caractérisé en ce que les parois latérales du flacon ont une structure stoppant au moins 95 % des radiations du visible.A package according to one of claims 1 to 4, characterized in that the side walls of the bottle have a structure which stops at least 95% of visible radiation. Un procédé de protection de fluorochromes sensibles à la lumière visible lors de leur conservation, dans lequel on installe lesdits fluorochromes dans un flacon dont au moins les parois latérales forment un écran efficace aux radiations du spectre lumineux entre 200 et 900 nm.A process for the protection of light-sensitive fluorochromes visible during storage, in which said fluorochromes are installed in a bottle of which at least the side walls form an effective shield against radiations of the light spectrum between 200 and 900 nm. Un procédé selon la revendication 6, caractérisé en ce que les parois latérales du flacon ont une structure stoppant au moins 95 % des radiations du visible.A method according to claim 6, characterized in that the side walls of the bottle have a structure which stops at least 95% of visible radiation.
    EP01430036A 2000-12-15 2001-12-05 Bottle for photosensitive dyes Expired - Lifetime EP1215135B1 (en)

    Applications Claiming Priority (2)

    Application Number Priority Date Filing Date Title
    FR0016445A FR2818254B1 (en) 2000-12-15 2000-12-15 PACKAGING FOR PHOTOSENSITIVE COLORANTS
    FR0016445 2000-12-15

    Publications (3)

    Publication Number Publication Date
    EP1215135A1 true EP1215135A1 (en) 2002-06-19
    EP1215135A8 EP1215135A8 (en) 2002-09-11
    EP1215135B1 EP1215135B1 (en) 2010-11-17

    Family

    ID=8857759

    Family Applications (1)

    Application Number Title Priority Date Filing Date
    EP01430036A Expired - Lifetime EP1215135B1 (en) 2000-12-15 2001-12-05 Bottle for photosensitive dyes

    Country Status (9)

    Country Link
    US (1) US6686004B2 (en)
    EP (1) EP1215135B1 (en)
    JP (1) JP4421154B2 (en)
    AT (1) ATE488451T1 (en)
    AU (1) AU780749B2 (en)
    DE (1) DE60143468D1 (en)
    ES (1) ES2353270T3 (en)
    FR (1) FR2818254B1 (en)
    NZ (1) NZ516118A (en)

    Cited By (1)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    CN105819108A (en) * 2016-05-18 2016-08-03 万臣塑料制品(上海)有限公司 Color changing package bottle manufacturing technology for daily chemical product industry and product

    Families Citing this family (4)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    FR2818254B1 (en) * 2000-12-15 2003-02-28 Immunotech Sa PACKAGING FOR PHOTOSENSITIVE COLORANTS
    FR2994740B1 (en) * 2012-08-21 2015-03-27 Horiba Abx Sas METHOD FOR COMPENSATING THE AGING OF A REAGENT DURING FLUORESCENCE MEASUREMENTS ON PARTICLES, AND BIOLOGICAL ANALYSIS DEVICE IMPLEMENTING THE METHOD
    US9583364B2 (en) 2012-12-31 2017-02-28 Sunedison Semiconductor Limited (Uen201334164H) Processes and apparatus for preparing heterostructures with reduced strain by radial compression
    CN113416022B (en) * 2021-06-30 2022-04-26 西安中核核仪器股份有限公司 Gamma detector energy response compensation material and use method thereof

    Citations (3)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    GB2086342A (en) * 1980-10-14 1982-05-12 Raffinage Cie Francaise Multilayer Containers
    JPH05127526A (en) * 1991-11-06 1993-05-25 Mita Ind Co Ltd Toner container
    US6117506A (en) * 1994-03-30 2000-09-12 Silgan Plastics Corporation Multilayer bottle with encapsulated dark layer

    Family Cites Families (4)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    US5110643A (en) * 1987-01-23 1992-05-05 Fuji Photo Film Co., Ltd. Packaging material for photosensitive materials
    US5750226A (en) * 1994-03-02 1998-05-12 Abbott Laboratories Light excluding multi-layer plastic barrier bottle
    FR2818254B1 (en) * 2000-12-15 2003-02-28 Immunotech Sa PACKAGING FOR PHOTOSENSITIVE COLORANTS
    FR2830253B1 (en) * 2001-09-28 2005-02-04 Air Liquide NOVEL PROCESS FOR THE PREPARATION OF C-FUNCTIONALIZED NITROGEN MACROCYCLES AND NOVEL INTERMEDIATES OBTAINED

    Patent Citations (3)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    GB2086342A (en) * 1980-10-14 1982-05-12 Raffinage Cie Francaise Multilayer Containers
    JPH05127526A (en) * 1991-11-06 1993-05-25 Mita Ind Co Ltd Toner container
    US6117506A (en) * 1994-03-30 2000-09-12 Silgan Plastics Corporation Multilayer bottle with encapsulated dark layer

    Non-Patent Citations (3)

    * Cited by examiner, † Cited by third party
    Title
    GLAZER ET AL., BIOPHYS. J., vol. 83, 1983, pages 383 - 386
    LANIER ET AL., METHODS, vol. 2, no. 3, 1991, pages 192 - 199
    PATENT ABSTRACTS OF JAPAN vol. 017, no. 498 (P - 1609) 8 September 1993 (1993-09-08) *

    Cited By (1)

    * Cited by examiner, † Cited by third party
    Publication number Priority date Publication date Assignee Title
    CN105819108A (en) * 2016-05-18 2016-08-03 万臣塑料制品(上海)有限公司 Color changing package bottle manufacturing technology for daily chemical product industry and product

    Also Published As

    Publication number Publication date
    AU9719801A (en) 2002-06-20
    AU780749B2 (en) 2005-04-14
    ATE488451T1 (en) 2010-12-15
    JP2002234581A (en) 2002-08-20
    NZ516118A (en) 2003-04-29
    US20020127356A1 (en) 2002-09-12
    US6686004B2 (en) 2004-02-03
    DE60143468D1 (en) 2010-12-30
    EP1215135A8 (en) 2002-09-11
    JP4421154B2 (en) 2010-02-24
    EP1215135B1 (en) 2010-11-17
    ES2353270T3 (en) 2011-02-28
    FR2818254A1 (en) 2002-06-21
    FR2818254B1 (en) 2003-02-28

    Similar Documents

    Publication Publication Date Title
    Jamin et al. Chemical heterogeneity in cell death: combined synchrotron IR and fluorescence microscopy studies of single apoptotic and necrotic cells
    JP2021193111A5 (en)
    Chen et al. Quantum Dot‐mediated Photoproduction of Reactive Oxygen Species for Cancer Cell Annihilation
    EP1215135B1 (en) Bottle for photosensitive dyes
    EP2964724B1 (en) Plastic scintillator materials, plastic scintillators comprising such materials and method for distinguishing neutrons from gamma rays using said scintillators
    FR2465311A1 (en) FLUORESCENT BRONZER LAMP
    RU2005130528A (en) FILM CONTAINING ABSORBED LIQUID, METHOD FOR PRODUCING IT AND PRODUCT
    FR2966044A1 (en) METHOD FOR CONDITIONING A VACCINE CONTAINING AN ALUMINUM ADJUVANT
    EP0771734A1 (en) Liquid dispensing bottle with a permeable membrane
    FR2491825A1 (en) MULTILAYER WALL CONTAINER
    Khmelinskii et al. Intermediate filaments in the retinal Müller cells as natural light energy guides
    EP0418335B1 (en) Process for the evaluation of the anti-oxidant activity of a chemical or physical agent by means of free radicals
    BRPI0609480A2 (en) ophthalmic lens inspection methods
    Masuda et al. Experimental evidence of distance-dependent diffusion coefficients of a globular protein observed in polymer aqueous solution forming a network structure on nanometer scale
    Rahmanzadeh et al. Two ways to inactivate the Ki‐67 protein—Fragmentation by nanoparticles, crosslinking with fluorescent dyes
    FR2951388A1 (en) SELECTIVE COLORING PROCESS
    CA2498239A1 (en) Use of an organic compound for absorbing ionizing radiation
    Yamashita et al. Clarification of degradation mechanism on retinal prosthesis using photoelectric dyes coupled to polyethylene film by mass spectrometry
    Quintin Qui a découvert la fluorescence X?
    FR3042690A1 (en) DEVICE AND METHOD FOR ENCAPSULATION OF FRAGRANCE SAMPLES OR OTHER LIQUIDS
    FR2855455A1 (en) METHOD FOR DECORATING A SUPPORT INCLUDING A TRANSPARENT OUTER LAYER
    FR2817969A1 (en) DEVICE AND METHOD FOR IMMUNOLOGICAL ANALYSIS
    Chundoo Synthesis and evaluation of nanoparticle-polymer composites
    FR2720508A1 (en) A method of demonstrating an analyte in a sample and a device for carrying out the method
    Meiklejohn et al. 5-Iodonaphthyl-1-azide labeling of plasma membrane proteins adjacent to specific sites via energy transfer

    Legal Events

    Date Code Title Description
    PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

    Free format text: ORIGINAL CODE: 0009012

    AK Designated contracting states

    Kind code of ref document: A1

    Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

    AX Request for extension of the european patent

    Free format text: AL;LT;LV;MK;RO;SI

    RIN1 Information on inventor provided before grant (corrected)

    Inventor name: DAZIANO, JEAN-PIERRE

    Inventor name: VAN AGTHOVEN, ANDRE

    AKX Designation fees paid

    Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

    17P Request for examination filed

    Effective date: 20030102

    17Q First examination report despatched

    Effective date: 20090206

    GRAP Despatch of communication of intention to grant a patent

    Free format text: ORIGINAL CODE: EPIDOSNIGR1

    GRAS Grant fee paid

    Free format text: ORIGINAL CODE: EPIDOSNIGR3

    GRAA (expected) grant

    Free format text: ORIGINAL CODE: 0009210

    AK Designated contracting states

    Kind code of ref document: B1

    Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

    REG Reference to a national code

    Ref country code: GB

    Ref legal event code: FG4D

    Free format text: NOT ENGLISH

    REG Reference to a national code

    Ref country code: CH

    Ref legal event code: EP

    REG Reference to a national code

    Ref country code: IE

    Ref legal event code: FG4D

    REF Corresponds to:

    Ref document number: 60143468

    Country of ref document: DE

    Date of ref document: 20101230

    Kind code of ref document: P

    REG Reference to a national code

    Ref country code: ES

    Ref legal event code: FG2A

    Effective date: 20110216

    REG Reference to a national code

    Ref country code: NL

    Ref legal event code: VDEP

    Effective date: 20101117

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: PT

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20110317

    Ref country code: AT

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20101117

    Ref country code: FI

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20101117

    Ref country code: SE

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20101117

    Ref country code: CY

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20101117

    Ref country code: NL

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20101117

    REG Reference to a national code

    Ref country code: IE

    Ref legal event code: FD4D

    BERE Be: lapsed

    Owner name: IMMUNOTECH

    Effective date: 20101231

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: GR

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20110218

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: MC

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20101231

    Ref country code: IE

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20101117

    REG Reference to a national code

    Ref country code: CH

    Ref legal event code: PL

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: DK

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20101117

    PLBE No opposition filed within time limit

    Free format text: ORIGINAL CODE: 0009261

    STAA Information on the status of an ep patent application or granted ep patent

    Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: BE

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20101231

    26N No opposition filed

    Effective date: 20110818

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: CH

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20101231

    Ref country code: LI

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20101231

    REG Reference to a national code

    Ref country code: DE

    Ref legal event code: R097

    Ref document number: 60143468

    Country of ref document: DE

    Effective date: 20110818

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: IT

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20101117

    REG Reference to a national code

    Ref country code: ES

    Ref legal event code: FD2A

    Effective date: 20120220

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: ES

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20101206

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: LU

    Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

    Effective date: 20101205

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: TR

    Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

    Effective date: 20101117

    REG Reference to a national code

    Ref country code: FR

    Ref legal event code: PLFP

    Year of fee payment: 15

    REG Reference to a national code

    Ref country code: FR

    Ref legal event code: PLFP

    Year of fee payment: 16

    REG Reference to a national code

    Ref country code: FR

    Ref legal event code: PLFP

    Year of fee payment: 17

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: FR

    Payment date: 20201112

    Year of fee payment: 20

    Ref country code: DE

    Payment date: 20201124

    Year of fee payment: 20

    Ref country code: GB

    Payment date: 20201125

    Year of fee payment: 20

    PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

    Ref country code: ES

    Payment date: 20210108

    Year of fee payment: 20

    REG Reference to a national code

    Ref country code: DE

    Ref legal event code: R071

    Ref document number: 60143468

    Country of ref document: DE

    REG Reference to a national code

    Ref country code: GB

    Ref legal event code: PE20

    Expiry date: 20211204

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: GB

    Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

    Effective date: 20211204

    REG Reference to a national code

    Ref country code: ES

    Ref legal event code: FD2A

    Effective date: 20220405

    PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

    Ref country code: ES

    Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

    Effective date: 20211206